5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | NEUTRAL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.20▼ | 3.14▲ | 3.15▲ | 3.27▼ | 2.82▲ |
MA10 | 3.19▼ | 3.14▲ | 3.17▼ | 3.14▲ | 2.53▲ |
MA20 | 3.15▲ | 3.18▼ | 3.23▼ | 2.86▲ | 2.62▲ |
MA50 | 3.14▲ | 3.29▼ | 3.30▼ | 2.46▲ | 6.90▼ |
MA100 | 3.19▼ | 3.29▼ | 2.99▲ | 2.66▲ | 7.27▼ |
MA200 | 3.28▼ | 2.97▲ | 2.73▲ | 5.85▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | 0.007▲ | -0.011▼ | 0.036▲ | 0.404▲ |
RSI | 49.432▼ | 45.083▼ | 44.117▼ | 58.840▲ | 44.218▼ |
STOCH | 52.030 | 46.327 | 26.818 | 69.702 | 72.026 |
WILL %R | -51.515 | -55.814 | -65.455 | -38.519 | -24.880▲ |
CCI | -14.096 | 88.071 | -12.055 | 31.335 | 191.082▲ |
CDL | $CATX Doji Candlestick Pattern Detected | Set Alert |
Saturday, May 31, 2025 05:03 PM
Perspective Therapeutics, Inc. (NYSE:CATX) has announced encouraging interim results from its ongoing Phase 1/2a clinical trial of [212Pb]VMT-α-NET, a targeted radiopharmaceutical for patients ...
|
Saturday, May 31, 2025 04:51 PM
Perspective Therapeutics, Inc. (NYSE:CATX) has announced encouraging interim results from its ongoing Phase 1/2a clinical trial of [212Pb]VMT-α-NET, a targeted radiopharmaceutical for patients with ...
|
Friday, May 30, 2025 02:30 PM
Perspective Therapeutics, Inc. presented updated interim results from its ongoing Phase 1/2a clinical trial of [212Pb]VMT-α-NET at the 2025 ASCO Annual Meeting, showing a favorable safety profile ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 3.16 | 3.29 | 3.04 | 3.17 | 815,900 |
12/06/25 | 3.40 | 3.41 | 3.16 | 3.22 | 524,800 |
11/06/25 | 3.52 | 3.66 | 3.25 | 3.28 | 1,107,500 |
10/06/25 | 3.325 | 3.69 | 3.29 | 3.465 | 2,018,982 |
09/06/25 | 3.43 | 3.60 | 3.23 | 3.23 | 1,364,300 |
06/06/25 | 3.21 | 3.57 | 3.16 | 3.32 | 1,404,700 |
05/06/25 | 3.10 | 3.35 | 2.96 | 3.12 | 1,233,200 |
04/06/25 | 3.21 | 3.38 | 3.05 | 3.13 | 2,068,300 |
03/06/25 | 2.44 | 3.66 | 2.44 | 3.09 | 8,712,700 |
02/06/25 | 2.68 | 2.71 | 2.34 | 2.39 | 1,386,032 |
|
|
||||
|
|
||||
|
|